The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription ...
The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback